These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
170 related articles for article (PubMed ID: 30350746)
1. Fatigue is common and severe in patients with mastocytosis. Omdal R; Skoie IM; Grimstad T Int J Immunopathol Pharmacol; 2018; 32():2058738418803252. PubMed ID: 30350746 [TBL] [Abstract][Full Text] [Related]
2. Fatigue in Mastocytosis: A Case Series. Vikse J; Omdal R Clin Ther; 2019 Apr; 41(4):625-632. PubMed ID: 30797624 [TBL] [Abstract][Full Text] [Related]
3. Targeting c-kit in the therapy of mast cell disorders: current update. El-Agamy DS Eur J Pharmacol; 2012 Sep; 690(1-3):1-3. PubMed ID: 22789565 [TBL] [Abstract][Full Text] [Related]
4. The Mastocytosis Society survey on mast cell disorders: patient experiences and perceptions. Jennings S; Russell N; Jennings B; Slee V; Sterling L; Castells M; Valent P; Akin C J Allergy Clin Immunol Pract; 2014; 2(1):70-6. PubMed ID: 24565772 [TBL] [Abstract][Full Text] [Related]
5. Mast Cell Disorders In Drug Hypersensitivity. Bonadonna P; Bonifacio M; Zanotti R Curr Pharm Des; 2016; 22(45):6862-6869. PubMed ID: 27779084 [TBL] [Abstract][Full Text] [Related]
6. Epidemiology, prognosis, and risk factors in mastocytosis. Brockow K Immunol Allergy Clin North Am; 2014 May; 34(2):283-95. PubMed ID: 24745674 [TBL] [Abstract][Full Text] [Related]
7. Diagnosis and classification of mastocytosis in non-specialized versus reference centres: a Spanish Network on Mastocytosis (REMA) study on 122 patients. Sánchez-Muñoz L; Morgado JM; Álvarez-Twose I; Matito A; Garcia-Montero AC; Teodosio C; Jara-Acevedo M; Mayado A; Mollejo M; Caldas C; González de Olano D; Escribano L; Orfao A Br J Haematol; 2016 Jan; 172(1):56-63. PubMed ID: 26456532 [TBL] [Abstract][Full Text] [Related]
8. Mast cells and inflammation. Frenzel L; Hermine O Joint Bone Spine; 2013 Mar; 80(2):141-5. PubMed ID: 23116710 [TBL] [Abstract][Full Text] [Related]
9. Diagnostic criteria and classification of mastocytosis in 2014. Akin C; Valent P Immunol Allergy Clin North Am; 2014 May; 34(2):207-18. PubMed ID: 24745670 [TBL] [Abstract][Full Text] [Related]
10. Mast cells in mastocytosis and allergy - Important player in metabolic and immunological homeostasis. Renke J; Kędzierska-Mieszkowska S; Lange M; Nedoszytko B; Wasilewska E; Liberek A; Renke M; Niedoszytko M; Witkowski J; Skórko-Glonek J; Lipińska B Adv Med Sci; 2019 Mar; 64(1):124-130. PubMed ID: 30641273 [TBL] [Abstract][Full Text] [Related]
11. In vivo model for mastocytosis: A comparative review. Ranieri G; Marech I; Pantaleo M; Piccinno M; Roncetti M; Mutinati M; Rizzo A; Gadaleta CD; Introna M; Patruno R; Sciorsci RL Crit Rev Oncol Hematol; 2015 Mar; 93(3):159-69. PubMed ID: 25465741 [TBL] [Abstract][Full Text] [Related]
12. Hymenoptera-induced anaphylaxis: is it a mast cell driven hematological disorder? Brockow K; Akin C Curr Opin Allergy Clin Immunol; 2017 Oct; 17(5):356-362. PubMed ID: 28796123 [TBL] [Abstract][Full Text] [Related]
13. The genetic basis of mast cell activation disease - looking through a glass darkly. Molderings GJ Crit Rev Oncol Hematol; 2015 Feb; 93(2):75-89. PubMed ID: 25305106 [TBL] [Abstract][Full Text] [Related]
15. Hymenoptera Allergy and Mast Cell Activation Syndromes. Bonadonna P; Bonifacio M; Lombardo C; Zanotti R Curr Allergy Asthma Rep; 2016 Jan; 16(1):5. PubMed ID: 26714690 [TBL] [Abstract][Full Text] [Related]
16. Mastocytosis and Anaphylaxis. Schuch A; Brockow K Immunol Allergy Clin North Am; 2017 Feb; 37(1):153-164. PubMed ID: 27886904 [TBL] [Abstract][Full Text] [Related]
17. Identification of activating c-kit mutations in adult-, but not in childhood-onset indolent mastocytosis: a possible explanation for divergent clinical behavior. Büttner C; Henz BM; Welker P; Sepp NT; Grabbe J J Invest Dermatol; 1998 Dec; 111(6):1227-31. PubMed ID: 9856847 [TBL] [Abstract][Full Text] [Related]
18. Current state of biology and diagnosis of clonal mast cell diseases in adults. Alvarez-Twose I; Morgado JM; Sánchez-Muñoz L; García-Montero A; Mollejo M; Orfao A; Escribano L Int J Lab Hematol; 2012 Oct; 34(5):445-60. PubMed ID: 22551157 [TBL] [Abstract][Full Text] [Related]
19. High prevalence of anaphylaxis in patients with systemic mastocytosis - a single-centre experience. Gülen T; Hägglund H; Dahlén B; Nilsson G Clin Exp Allergy; 2014 Jan; 44(1):121-9. PubMed ID: 24164252 [TBL] [Abstract][Full Text] [Related]
20. Venom immunotherapy in patients with mastocytosis and hymenoptera venom anaphylaxis. González-de-Olano D; Alvarez-Twose I; Vega A; Orfao A; Escribano L Immunotherapy; 2011 May; 3(5):637-51. PubMed ID: 21554093 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]